Design Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Design Therapeutics's balance sheet done over the years? Its assets were worth $289,643,000 last year, which is less than in the previous period. 4% of Design Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $11,956,000, which means an decrease by -14% compared compared to last year.

Debt to Assets

Design Therapeutics, Inc. (NASDAQ:DSGN): Debt to assets
2019 90000 3.73M 4146.67%
2020 36516000 47.83M 130.99%
2021 390557000 8.42M 2.16%
2022 341137000 13.82M 4.05%
2023 289643000 11.95M 4.13%

DSGN Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
21.2M26.5M298.56M2.37M77K
Short term investments
260.59M303.88M85.49M33.71M0
Net receivables
1.43M1.11M110K10K0
Inventory
0-1.11M1.25M107K0
Other current assets
1.35M4.73M7K25K13K
Total current assets
284.58M335.11M385.43M36.23M90K
Non-current assets:
Property, Plant and Equipment
4.62M5.55M5.12M71K0
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
430K459K0212K0
Total non-current assets
5.05M6.01M5.12M283K0
Total assets
289.64M341.13M390.55M36.51M90K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000201K
Short term debt
716K640K489K0695K
Total current liabilities
9.62M10.77M5.28M2.33M3.73M
Non-current liabilities:
Long term debt
2.33M3.05M3.14M00
Deferred tax
00000
Other non-current liabilities
00045.50M1K
Total non-current liabilities
2.33M3.05M3.14M45.50M1K
Total liabilities
11.95M13.82M8.42M47.83M3.73M
Data sourceData sourceData source